Tag: Anoro ellipta

Unlike many inhalers used for respiratory conditions, the medication ANORO is not typically associated with causing thrush. This is because it does not contain an inhaled corticosteroid, which is the class of drug most frequently linked to oral fungal infections. Understanding this distinction is key for managing expectations and maintaining good oral health.

According to the FDA, Anoro Ellipta was first approved in 2013 for the long-term, once-daily maintenance treatment of airflow obstruction in adults with Chronic Obstructive Pulmonary Disease (COPD). What is Anoro Ellipta and how does its pharmacology help patients with chronic bronchitis and emphysema achieve better breathing?